Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone
- 1 December 1982
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 233 (1) , 235-247
- https://doi.org/10.1016/s0378-4347(00)81750-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- ACTIVITY OF A NOVEL ANTHRACENYL BISHYDRAZONE, 9,10-ANTHRACENEDICARBOXALDEHYDE BIS[4,5-DIHYDRO-1H-IMIDAZOL-2-YL)HYDRAZONE] DIHYDROCHLORIDE, AGAINST EXPERIMENTAL-TUMORS IN MICE1982
- PHASE-1 CLINICAL INVESTIGATION OF 9,10-ANTHRACENEDICARBOXALDEHYDE BIS[(4,5-DIHYDRO-H-1-IMIDAZOL-2-YL)HYDRAZONE] DIHYDROCHLORIDE WITH CORRELATIVE INVITRO HUMAN TUMOR CLONOGENIC-ASSAY1982
- High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokineticsLife Sciences, 1981
- Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drugCancer Chemotherapy and Pharmacology, 1980
- An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in SerumJournal of Liquid Chromatography, 1980
- EXPERIMENTAL ANTI-TUMOR ACTIVITY OF AMINOANTHRAQUINONES1979